Skip to main content
Clinical Trials/NCT03996551
NCT03996551
Completed
Not Applicable

ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study. A Feasibility Randomised Controlled Trial.

King's College Hospital NHS Trust2 sites in 1 country17 target enrollmentSeptember 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Transplant; Complications
Sponsor
King's College Hospital NHS Trust
Enrollment
17
Locations
2
Primary Endpoint
Feasibility- proportion of participants willing to be randomized
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The primary aim of this trial is to assess the feasibility of a novel online weight gain prevention resource for new kidney transplant recipients at two London transplant clinics. A previous study conducted by the research team titled 'ExeRTiOn' provided usability feedback that led to revisions of this online resource in a purposive sample of kidney transplant recipients (n=11) and transplant multidisciplinary team members (n=6).

Detailed Description

This current study aims to recruit a sample of new kidney transplant recipients (n=50) from two transplant sites in London. Participants will be randomized to either the 12-week kidney transplant specific novel online weight gain prevention resource (n=25) or usual care (n=25). All participants will be assessed at baseline, 12 weeks and 12 months. The primary outcome of this study is feasibility (screening, recruitment, randomization, retention, adherence to the intervention and adherence to the study visits). The research team will also assess the ability to collect measures for a definitive study (body weight, body mass index, body composition, quality of life, self-efficacy, fatigue, arterial stiffness and physical function). A nested qualitative study will capture participant experience at two time points during this 12 month trial. At 3 months semi-structured individual interviews will be conducted in a purposive approximately 6 to 10 of the intervention participants until data saturation is achieved. These interviews will assess the experience of using the online intervention. At 6 months a purposive sample of approximately 16 participants from both groups will complete individual semi-structured interviews to assess the experiences of participating in this trial.

Registry
clinicaltrials.gov
Start Date
September 20, 2019
End Date
June 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
King's College Hospital NHS Trust
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age 18 or above
  • able to provide written consent
  • less than 3 months post kidney transplant
  • access to the internet connected computer, tablet, laptop or smartphone
  • a body mass index greater than or equal to 18.5 (healthy range)

Exclusion Criteria

  • age \< 18
  • current pregnancy
  • unstable medication condition such as uncontrolled angina
  • participation in a recent structured exercise programme in the last 3 months
  • BMI of less than 18.5 (classified as underweight)
  • significant cognitive impairment preventing them from engaging with the online resource
  • unable to complete the resource in English

Outcomes

Primary Outcomes

Feasibility- proportion of participants willing to be randomized

Time Frame: through study completion, an average of 1 year

willingness of participants to be randomized to each group

feasibility- total retention of participants over the trial period

Time Frame: through study completion, an average of 1 year

number of participants retained and at end of study

Feasibility- screening of participants

Time Frame: through study completion, an average of 1 year

number of participants screened per month, and those unwilling to take part

feasibility- monthly retention of participants over the trial period

Time Frame: through study completion, an average of 1 year

number of participants retained per month

feasibility-adherence to ExeRTiOn online resource (intervention group)

Time Frame: by three months

aim for 60% completion of sessions

feasibility- time taken to complete all study visits

Time Frame: through study completion, an average of 1 year

the average time taken to complete study visits will be captured

feasibility- adherence to study visits throughout the trial

Time Frame: through study completion, an average of 1 year

the proportion of completed study visits for outcome measures will be calculated

feasibility- qualitative experience of participants using the online resource

Time Frame: 3 months

individual semi-structured interviews in a purposive sample from the treatment group

feasibility- qualitative experience of participants participation in the trial

Time Frame: 6 months

individual semi-structured interviews in a purposive sample of study participants

Feasibility- recruitment of participants into the trial

Time Frame: through study completion, an average of 1 year

number of participants recruited per month

feasibility- safety throughout the trial

Time Frame: 12 months

the number of hospital admissions (non-elective, or elective staying \>24 hours) will be captured

Secondary Outcomes

  • body mass index over the 12 month trial(baseline, 3 months, 12 months)
  • self reported self-efficacy for physical exercise scale over the 12 month trial(baseline, 3 months, 12 months)
  • Total score self reported fatigue via the Chalder Fatigue Questionnaire over the 12 months(baseline, 3 months, 12 months)
  • body composition over the 12 month trial(baseline, 3 months, 12 months)
  • quality of life (self-reported) over the 12 month trial(baseline, 3 months, 12 months)
  • change in body weight in kilograms over the trial(baseline, 3 months and 12 months)
  • Mental fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months(baseline, 3 months, 12 months)
  • physical function over the 12 month trial(baseline, 3 months, 12 months)
  • Physical fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months(baseline, 3 months, 12 months)
  • arterial stiffness over the 12 month trial(at baseline, 3 months and 12 months)
  • self reported self-efficacy for nutrition scale over the 12 month trial(baseline, 3 months, 12 months)

Study Sites (2)

Loading locations...

Similar Trials